General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
Operating Status
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Atrin Pharmaceuticals
Atrin Pharmaceuticals is a biopharmaceutical company that is revolutionizing cancer treatment.
Sector
Subsector
Location
total rounds
total raised
ApopLogic Pharmaceuticals
ApopLogic Pharmaceuticals develops and sells cancer treatments targeting apoptotic cell death.
Sector
Subsector
Location
Actelion Pharmaceuticals
Actelion Ltd is a biopharmaceutical company that develops and sells low molecular weight drugs for various medical needs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Ampio Pharmaceuticals
Ampio Pharmaceuticals develops innovative drugs to improve patient care.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds1
Number of Funding Rounds
Their latest funding was raised on 01.01.1993. Their latest investor Venrock. Their latest round Seed
Co-Investors
Investors1
Number of lead investors
Number of investors
Venrock
Venrock partners with entrepreneurs to build disruptive, successful companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Acquisitions2
COR Therapeutics Inc acquired by Millennium Pharmaceuticals
acquirer
date
type
price
COR Therapeutics Inc
COR Therapeutics develops and markets therapeutic products for cardiovascular diseases.
Sector
Subsector
Keywords
Location
LeukoSite acquired by Millennium Pharmaceuticals
acquirer
date
type
price
LeukoSite
LeukoSite develops antibody treatment and care.
Sector
Subsector
Location
total rounds
total raised
People
Founders2
Raju Kucherlapati
Raju Kucherlapati, Ph.D. has served as a director since October 2001. He has been a professor of Medicine at Harvard Medical School since 2001 and served as scientific director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics from 2001 to 2008. Dr. Kucherlapati was a founder of Cell Genesys, Inc., Abgenix, Inc. and Millennium Pharmaceuticals, Inc. and currently serves on the board of Enlight Biosciences LLC. Dr. Kucherlapati holds a B.S. in Biology from P.R. College, Kakinada, India, an M.S. in biology from Andhra University, Waltair, India and a Ph.D. from the University of Illinois at Urbana.
current job
organization founded
Raju Kucherlapati
Eric Lander
Eric Lander, Ph.D., is a co-founder of Infinity. Lander has been a professor and associate professor of biology at the Massachusetts Institute of Technology since 1990 and a professor of systems biology at Harvard Medical School since 2004. Lander has served as the founding director of The Eli and Edythe L. Broad Institute, a biomedical research institute formed by MIT and Harvard University, since 2003 and as a member of the Whitehead Institute for Biomedical Research since 1989. From 1993-2003, Dr. Lander was the director of the Whitehead/MIT Center for Genome Research. Lander received an A.B. in mathematics from Princeton University and a D.Phil. in mathematics from Oxford University, which he attended as a Rhodes Scholar.
current job
organization founded
Eric Lander
Employee Profiles144
Tetsu Inada
Chief financial officer and vp, global vaccines
Tamyra A. Toole
Regulatory Affairs and Quality Assurance